Non-compliance with antibiotic therapy for acute community infections: a global survey

International Journal of Antimicrobial Agents

Volumn 29, Issue 3, 2007, Pages 245-253

  Pechère, Jean Claude ^a   Hughes, Dyfrig ^b   Kardas, Przemyslaw ^c   Cornaglia, Giuseppe ^d  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b BANGOR UNIVERSITY   (United Kingdom)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Antibiotics; Bacterial resistance; Non compliance; Patient physician interactions

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; CHINA; CLUSTER ANALYSIS; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG USE; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ATTITUDE; COMMUNITY-ACQUIRED INFECTIONS; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TREATMENT REFUSAL;

EID: 33846934249     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.09.026     Document Type: Short Survey

References (39)

1. Kardas P., Devine S., Golembesky A., and Roberts C. A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Int J Antimicrob Agents 26 (2005) 106-113
2. Green J.L., Ray S.P., and Charney E. Recurrence rate of streptococcal pharyngitis related to oral penicillin. J Pediatr 75 (1969) 292-294
3. Jordan W.C. Doxycycline vs. tetracycline in the treatment of men with gonorrhea: the compliance factor. Sex Transm Dis 8 (1981) 105-109
4. Alger L.S., and Lovchik J.C. Comparative efficacy of clindamycin versus erythromycin in eradication of antenatal Chlamydia trachomatis. Am J Obstet Gynecol 165 (1981) 375-381
5. Anastasio G.D., Little Jr. J.M., Robinson M.D., Pettice Y.L., Leitch B.B., and Norton U.J. Impact of compliance and side effects on the clinical outcome of patients treated with oral erythromycin. Pharmacotherapy 14 (1994) 229-234
6. Cheung R., Sullens C.M., Seal D., et al. The paradox of using a 7-day antibacterial course to treat urinary tract infections in the community. Br J Clin Pharmacol 26 (1988) 391-398
7. Venuta A., Laudizi L., Beverelli A., Bettelli F., Milioli S., and Garetti E. Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children. J Int Med Res 26 (1998) 152-158
8. Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 360 (2002) 835-841 [Erratum. Lancet 2003;361:788.]
9. Agarwal G., Awasthi S., Kabra S.K., Kaul A., Singhi S., Walter S.D., and ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 328 (2004) 791
10. Nicolau D. Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections. J Antimicrob Chemother 50 Suppl. S1 (2002) 61-70
11. Dajani A.S. Adherence to physicians' instructions as a factor in managing streptococcal pharyngitis. Pediatrics 97 (1996) 976-980
12. Pechère J.C. Parameters important in short antibiotic courses. J Int Med Res 28 Suppl. 1 (2000) 3A-12A
13. Sclar D.A., Tartaglione T.A., and Fine M.J. Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. Infect Agents Dis 3 (1994) 266-273
14. Barron J.J., Grochulski W.D., Merchant S., Spooner J.J., Waugh W.J., and Keating K.N. Treatment costs associated with commonly used branded antibiotics for the management of acute sinusitis, chronic bronchitis and pneumonia. J Applied Res 4 (2004) 24-36
15. Miravitlles M., Murio C., Guerrero T., Gisbert R., and for the DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121 (2002) 1449-1455
16. Thomas J.K., Forrest A., Bhavnani S.M., et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 42 (1998) 521-527
17. Pechère J.C. Patient's interviews and misuse of antibiotics. Clin Infect Dis 33 Suppl. 3 (2001) S170-S173
18. Guillemot D., Carbon C., Balkau B., et al. Low dosage and long treatment duration of β-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279 (1998) 365-370
19. Schrag S.J., Peña C., Fernández J., et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 286 (2001) 49-56
20. Branthwaite A., and Pechère J.C. Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res 24 (1996) 229-238
21. Pechère J.-C., Cenedese C., Müller O., et al. Attitudinal classification of patients receiving antibiotic treatment for mild respiratory tract infections. Int J Antimicrob Agents 20 (2002) 399-406
22. Rabin R., and de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33 (2001) 337-343
23. Claxton A.J., Cramer J., and Pierce C. A systematic review of the association between dose regimens and medication compliance. Clin Ther 23 (2001) 1296-1310
24. Matsushima D., Okayama M., Matsushima E., Ohno S., and Kajii E. Relation between the actual and ideal consultation time in the outpatient setting. Jpn J Prim Care 27 (2004) 179-185
25. Tomiki Y., Kanai Y., Danbara T., et al. Survey of outpatient waiting time. Juntendoigaku 49 (2003) 102-107
26. IMS Japan KK, MDI (Medical Data Index) in 2001-2004, with permission.
27. Reyes H., Guiscafre H., Muñoz O., Perez-Cuevas R., Martinez H., and Gutierrez G. Antibiotic non-compliance and waste in upper respiratory infections and acute diarrhea. J Clin Epidemiol 50 (1997) 1297-1304
28. European Antimicrobial Resistance Surveillance System (EARSS). Annual Report 2003. http://www.rivm.nl/earss/result/Monitoring_reports/ [accessed 2 November 2006].
29. Carey B., and Cryan B. Antibiotic misuse in the community-a contributor to resistance?. Ir Med J 96 (2003) 43-45
30. Greenberg R.N. Overview of patient compliance with medication dosing: a literature review. Clin Ther 6 (1984) 592-599
31. Cockburn J., Reid A.L., Bowman J.A., et al. Effects of intervention on antibiotic compliance in patients in general practice. Med J Aust 147 (1987) 324-328
32. Cockburn J., Gibberd R.W., Reid A.L., and Sanson-Fisher R.W. Determinants of non-compliance with short-term antibiotic regimens. Br Med J (Clin Res Ed) 295 (1987) 814-818
33. Kardas P. Once-daily dosage secures better compliance with antibiotic therapy of respiratory tract infections than twice-daily dosage. J Appl Res 3 (2003) 2001-2006
34. Bergman A.B., and Werner R.J. Failure of children to receive penicillin by mouth. N Engl J Med 268 (1963) 1334-1338
35. Polk R. Optimal use of modern antibiotics: emerging trends. Clin Infect Dis 29 (1999) 264-274
36. World Health Organization. WHO Report on Infectious Diseases, 2000: overcoming antimicrobial resistance. Geneva, Switzerland: WHO. WHO/CDS 2000;2:62.
37. Perez-Gorricho B., Ripoll M., and PACE Study Group. Does short-course antibiotic therapy better meet patient expectations?. Int J Antimicrob Agents 21 (2003) 222-228
38. File Jr. M. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia. Clin Infect Dis 39 Suppl. 3 (2004) S159-S164
39. Epstein B.J., Gums J.G., and Drlica K. The changing face of antibiotic prescribing: the mutant selection window. Ann Pharmacother 38 (2004) 1675-1682